SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-145685
Filing Date
2021-12-02
Accepted
2021-12-02 07:53:50
Documents
14
Period of Report
2021-12-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2134414d1_8k.htm   iXBRL 8-K 36678
2 EXHIBIT 99.1 tm2134414d1_ex99-1.htm EX-99.1 20608
6 GRAPHIC tm2134414d1_ex99-1img001.jpg GRAPHIC 6774
  Complete submission text file 0001104659-21-145685.txt   248010

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA omer-20211201.xsd EX-101.SCH 3019
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE omer-20211201_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omer-20211201_pre.xml EX-101.PRE 22355
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2134414d1_8k_htm.xml XML 3488
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34475 | Film No.: 211464978
SIC: 2834 Pharmaceutical Preparations